You are here

  • Home
  • Impact
  • Publications
  • The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US

The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US

Earnshaw, S., Graham, C., Amonkar, MM., & Barr, CE. (2006). The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US. Value in Health, 9(3), A163-A163.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Nanoparticle technology for respiratory tract mucosal vaccine delivery
Article

Consequential effects of increased use of recycled fiber in the United States pulp and paper industry
Article

A housing mobility program's impacts on teen and young adult parenting
Article

Self-reported sexually-transmitted infections and criminal justice involvement among women who use drugs

RTI uses cookies to offer you the best experience online. By continuing to use our website, you agree to the use of cookies. If you would like to know more about cookies and how to manage them please view our Privacy Policy. Learn More.

Got it!